NCT01845272

Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine Besylate

Open-label, Randomized, Single-dose, Crossover Study to Evaluate the Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine Besylate in Healthy Male Volunteers.

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: HK inno.N Corporation · Industry
• Sex: Male
• Age: 20 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This study is designated to evaluate the pharmacokinetic interactions of candesartan cilexetil and amlodipine besylate in healthy male volunteers.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	candesartan cilexetil 32mg, amlodipine 10mg	Treatment A (candesartan 10 days), at least 4 days wash-out, Treatment B (candesartan + amlodipine 10 days, 2-period, 2-treatment crossover
DRUG	candesartan cilexetil 32mg, amlodipine 10mg	Treatment A (amlodipine 10 days), at least 4 days wash-out, Treatment B (candesartan + amlodipine 10 days, 2-period, 2-treatment crossover

Timeline

• Start date: 2013-04-01
• Primary completion: 2013-07-01
• Completion: 2013-08-01
• First posted: 2013-05-03
• Last updated: 2013-05-03